Literature DB >> 19614769

Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate.

Beda Mühleisen1, Ivaylo Petrov, Tamara Gächter, Michael Kurrer, Leo Schärer, Reinhard Dummer, Lars E French, Günther F L Hofbauer.   

Abstract

AIMS: Squamous cell carcinoma of the skin (SCC) increases dramatically in organ transplant recipients (OTRs). The aim was to determine whether qualitative and quantitative differences in perineoplastic inflammation in OTRs contribute to the increased carcinogenesis. METHODS AND
RESULTS: We studied the perineoplastic inflammatory infiltrate in SCC, assessing depth, density and phenotype (CD3, 4, 8, FOXP3, CD123 and STAT1) by immunohistochemistry in paired biopsy specimens of intraepithelial and invasive SCC in immunocompetent patients and OTRs. Considerable inflammation was observed in all intraepithelial SCC (inflammatory infiltrate depth 2.80 +/- 2.21 mm immunocompetent patients, 2.15 +/- 2.95 mm OTRs). Inflammation was more pronounced in invasive SCC of immunocompetent patients (4.60 +/- 4.67 mm) and OTRs (3.30 +/- 5.90 mm) (P < 0.005). The density of perineoplastic inflammatory infiltrates increased from intraepithelial to invasive SCC (P = 0.005). OTRs showed a lower density of perineoplastic inflammatory infiltrate (P = 0.041). OTRs also showed reduced CD3+ T-lymphocyte and CD8+ cytotoxic T-lymphocyte proportions in intraepithelial SCC (P = 0.025 and 0.027, respectively). FOXP3+ regulatory T-lymphocyte proportions in OTRs' invasive SCC were markedly diminished (P = 0.048). CD123+ plasmacytoid dendritic cells increased in the progression from intraepithelial to invasive SCC in immunocompetent patients (P = 0.040). CD123+ cells were reduced in all SCC of OTRs (P = 0.036).
CONCLUSIONS: Perineoplastic inflammation in intraepithelial SCC is pronounced both in immunocompetent patients and OTRs. Inflammation increases further in invasive SCC. OTRs show reduced proportions of FOXP3+ regulatory T cells and CD123+ plasmacytoid dendritic cells. This distinct inflammatory infiltrate may result in increased cutaneous carcinogenesis and more aggressive behaviour of SCC in OTRs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19614769     DOI: 10.1111/j.1365-2559.2009.03324.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  13 in total

Review 1.  The contribution of Langerhans cells to cutaneous malignancy.

Authors:  Julia Lewis; Renata Filler; Debra A Smith; Kseniya Golubets; Michael Girardi
Journal:  Trends Immunol       Date:  2010-11-09       Impact factor: 16.687

Review 2.  Roles of the immune system in skin cancer.

Authors:  S Rangwala; K Y Tsai
Journal:  Br J Dermatol       Date:  2011-11       Impact factor: 9.302

3.  Knowledge, understanding, and use of preventive strategies against nonmelanoma skin cancer in healthy and immunosuppressed individuals undergoing Mohs surgery.

Authors:  Alina Goldenberg; Bichchau Thi Nguyen; Shang I Brian Jiang
Journal:  Dermatol Surg       Date:  2013-12-19       Impact factor: 3.398

4.  Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma.

Authors:  Melody Abikhair Burgo; Nazanin Roudiani; Jie Chen; Alexis L Santana; Nicole Doudican; Charlotte Proby; Diane Felsen; John A Carucci
Journal:  JCI Insight       Date:  2018-09-06

5.  Distinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patients.

Authors:  Beda Muehleisen; Shang Brian Jiang; Julie A Gladsjo; Monika Gerber; Tissa Hata; Richard L Gallo
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

6.  S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.

Authors:  Guergana Iotzova-Weiss; Piotr J Dziunycz; Sandra N Freiberger; Severin Läuchli; Jürg Hafner; Thomas Vogl; Lars E French; Günther F L Hofbauer
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

7.  Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage.

Authors:  Andrew Freeman; Jennifer A Bridge; Pirashanthini Maruthayanar; Nana H Overgaard; Ji-Won Jung; Fiona Simpson; Tarl W Prow; H Peter Soyer; Ian H Frazer; Michael Freeman; James W Wells
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

Review 8.  The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis.

Authors:  Bogusław Nedoszytko; Magdalena Lange; Małgorzata Sokołowska-Wojdyło; Joanna Renke; Piotr Trzonkowski; Michał Sobjanek; Aneta Szczerkowska-Dobosz; Marek Niedoszytko; Aleksandra Górska; Jan Romantowski; Justyna Czarny; Jarosław Skokowski; Leszek Kalinowski; Roman Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2017-10-31       Impact factor: 1.837

9.  CD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients.

Authors:  Matthew J Bottomley; Paul N Harden; Kathryn J Wood
Journal:  J Am Soc Nephrol       Date:  2015-11-12       Impact factor: 10.121

10.  OX40+ Regulatory T Cells in Cutaneous Squamous Cell Carcinoma Suppress Effector T-Cell Responses and Associate with Metastatic Potential.

Authors:  Chester Lai; Suzannah August; Amel Albibas; Ramnik Behar; Shin-Young Cho; Marta E Polak; Jeffrey Theaker; Amanda S MacLeod; Ruth R French; Martin J Glennie; Aymen Al-Shamkhani; Eugene Healy
Journal:  Clin Cancer Res       Date:  2016-03-31       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.